Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,357,222
  • Shares Outstanding, K 25,579
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,630 K
  • 60-Month Beta 1.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 55.11
Trade SAVA with:

Options Overview

Details
  • Implied Volatility 135.21%
  • Historical Volatility 410.85%
  • IV Percentile 28%
  • IV Rank 9.25%
  • IV High 492.41% on 03/16/20
  • IV Low 98.79% on 12/10/20
  • Put/Call Vol Ratio 0.33
  • Today's Volume 4,036
  • Volume Avg (30-Day) 19,578
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 55,314
  • Open Int (30-Day) 78,219

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.48 +255.25%
on 01/26/21
117.54 -56.24%
on 02/04/21
+35.76 (+228.06%)
since 01/25/21
3-Month
6.70 +667.76%
on 12/29/20
117.54 -56.24%
on 02/04/21
+43.74 (+568.05%)
since 11/25/20
52-Week
1.63 +3,055.83%
on 05/15/20
117.54 -56.24%
on 02/04/21
+44.59 (+650.95%)
since 02/25/20

Most Recent Stories

More News
United Therapeutics (UTHR) Q4 Earnings Miss, Sales Beat

United Therapeutics' (UTHR) fourth-quarter earnings miss estimates while sales beat the same. Higher sales of Orenitram, Remodulin and Tyvaso offset lower sales of Unituxin and Adcirca.

MDT : 117.91 (-0.70%)
LLY : 203.18 (-0.66%)
UTHR : 170.67 (-1.74%)
SAVA : 50.93 (-4.01%)
Jazz Pharma (JAZZ) Q4 Earnings Miss, 2021 Sales View Dull

Jazz Pharmaceuticals (JAZZ) reports mixed fourth-quarter 2020 results as earnings miss estimates while sales beat the same. Shares down.

JAZZ : 171.08 (-1.39%)
USNA : 96.26 (+2.64%)
GWPH : 215.20 (+0.09%)
SAVA : 50.93 (-4.01%)
Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know

Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $52.37, moving -1.23% from the previous trading session.

SAVA : 50.93 (-4.01%)
Cassava Sciences (SAVA) to Post Q4 Earnings: What's in Store?

Cassava Sciences (SAVA) will provide updates on its pipelinewhen it reports fourth-quarter 2020 results.

MRNA : 149.53 (+3.27%)
AVIR : 81.90 (+2.38%)
SAVA : 50.93 (-4.01%)
CSTL : 75.83 (-8.87%)
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer's disease, has been invited to present at the 10th Annual SVB Leerink Global Healthcare...

SAVA : 50.93 (-4.01%)
Cassava Sciences Announces Positive End-of-Phase 2 Meeting with FDA and Outlines Pivotal Phase 3 Program for Simufilam in Alzheimer's Disease

- Two Upcoming Phase 3 Studies and a Previously Completed Phase 2 Program Support a New Drug Application Filing for Simufilam in Alzheimer's disease -

SAVA : 50.93 (-4.01%)
Thinking about trading options or stock in Kohl's, Cassava Sciences, Caterpillar, United Airlines, or Foot Locker?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KSS, SAVA, CAT, UAL, and FL.

SAVA : 50.93 (-4.01%)
UAL : 52.15 (-5.11%)
CAT : 223.02 (+0.25%)
FL : 53.47 (-2.34%)
KSS : 55.44 (-0.45%)
Is Cassava Sciences (SAVA) Stock Outpacing Its Medical Peers This Year?

Is (SAVA) Outperforming Other Medical Stocks This Year?

SAVA : 50.93 (-4.01%)
Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know

Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $51.22, moving -1.18% from the previous trading session.

SAVA : 50.93 (-4.01%)
Dow Stays in Record Territory to Start Short Week

Dow Stays in Record Territory to Start Short Week

BABA : 243.14 (-2.88%)
VIRT : 28.31 (+4.85%)
SWKS : 178.44 (-6.26%)
MAR : 151.75 (-3.65%)
INTU : 392.06 (-5.11%)
NUAN : 43.05 (-3.93%)
F : 11.88 (-3.18%)
CWH : 33.44 (-10.03%)
TMHC : 27.35 (-6.75%)
EMKR : 6.84 (-2.70%)
PRIM : 34.70 (-3.05%)
TEX : 41.79 (-2.93%)
SQ : 230.20 (-3.00%)
CDAY : 87.19 (-3.30%)
HTHT : 58.64 (-0.37%)
VLO : 79.03 (+1.11%)
XPO : 115.61 (-2.13%)
CCJ : 16.52 (+2.23%)
SLB : 28.90 (-1.73%)
JO : 40.25 (+1.77%)
TAL : 78.68 (-3.27%)
TDC : 41.74 (-4.44%)
VSAT : 53.41 (-2.77%)
NIB : 33.12 (+2.01%)
BMRN : 82.50 (-0.98%)
AA : 25.96 (-4.56%)
VSTO : 32.94 (-1.20%)
KBH : 40.07 (-3.70%)
SAVA : 50.93 (-4.01%)
X : 17.81 (-7.77%)
APHA : 18.66 (-7.03%)
HEXO : 7.18 (-7.59%)
ACB : 11.06 (-4.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 57.94
2nd Resistance Point 56.26
1st Resistance Point 54.66
Last Price 50.93
1st Support Level 51.39
2nd Support Level 49.71
3rd Support Level 48.11

See More

52-Week High 117.54
Fibonacci 61.8% 73.26
Fibonacci 50% 59.58
Last Price 50.93
Fibonacci 38.2% 45.91
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar